Connect your AI

Medifast MED Payments to Acquire Debt Securities, Available-for-Sale

Payments to Acquire Debt Securities, Available-for-Sale at other companies

First BanCorpFBP

$767.69M+6,160%

SB Financial GroupSBFG

$100K-76.1%

Mercantile Bank CorporationMBWM

$42.93M-16.9%

BCB BancorpBCBP

$15.61M+5.1%

USCB Financial Holdings, Inc.USCB

$13.63M-3.5%

Trustco Bank CorpTRST

$25.08M+153%

Other financials

Income statement

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's payments to acquire debt securities, available-for-sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medifast's payments to acquire debt securities, available-for-sale?: Medifast (MED) reported payments to acquire debt securities, available-for-sale of $49.32M in Q1 2026.
How has Medifast's payments to acquire debt securities, available-for-sale changed year-over-year?: Medifast's payments to acquire debt securities, available-for-sale increased by 229.0% year-over-year, from $14.99M to $49.32M.